Protective Effects of Toll-like Receptor 4 Inhibitor Eritoran on Renal Ischemia-Reperfusion Injury
Authors:
- M. LiuMLM. Liu
- M. GuMGM. Gu
- 1 June 2010
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 42 (5) , 1539-1544
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Chronic allograft nephropathyPediatric Nephrology, 2009
- Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Posttreatment with Aminoguanidine Attenuates Renal Ischemia/Reperfusion Injury in RatsRenal Failure, 2009
- The innate immune response in ischemic acute kidney injuryClinical Immunology, 2009
- Ischemia- reperfusion Injury and Its Influence on the Epigenetic Modification of the Donor Kidney GenomeTransplantation, 2008
- Inflammation in Acute Kidney InjuryNephron Experimental Nephrology, 2008
- Scientific basis of organ preservationCurrent Opinion in Organ Transplantation, 2008
- Toll-like receptor signaling in the ischemic heartFrontiers in Bioscience-Landmark, 2008
- TLR4 activation mediates kidney ischemia/reperfusion injuryJournal of Clinical Investigation, 2007
- Toll receptors: an expanding role in our understanding of human diseaseJournal of Leukocyte Biology, 2000